Extra time and breaks didn’t help kids with ADHD in a 255-child trial. Medication and behavior therapy did
Some of the most common school supports for attention-deficit/hyperactivity disorder made no measurable difference in classroom behavior or schoolwork, researchers report in JAMA Pediatrics. Here’s what that means for a child’s IEP or 504 plan.
Four of the most common classroom supports for children with ADHD, extra time on assignments, frequent breaks, a standing desk and a quiet place to work, did not measurably improve the children’s behavior or schoolwork in a new randomized trial, researchers at Florida International University reported in the journal JAMA Pediatrics. Stimulant medication and behavior therapy, by contrast, both cut rule-breaking in class, and medication also helped children get more work done and score higher on quizzes.
“We were surprised that none of the accommodations we tested had a significant effect, even when combined with behavioral interventions or medication,” said Gregory Fabiano, an FIU psychology professor and the study’s lead author. ADHD, or attention-deficit/hyperactivity disorder, makes it hard for children to focus, sit still or control impulses. FIU, citing the Centers for Disease Control and Prevention, said about 7.1 million U.S. children ages 3 to 17, nearly 12%, had a current ADHD diagnosis in 2024.
What it means for parents
Many children with ADHD get these accommodations through an IEP, an Individualized Education Program for students in special education, or a Section 504 plan, which gives students with disabilities changes in how they learn or are tested. The researchers do not say accommodations should be dropped. “There may be times when accommodations may be helpful, but a ‘one size fits all’ approach to ADHD doesn’t seem to be effective,” Fabiano said.
Fabiano’s explanation is that accommodations change the conditions around a child but do not teach new skills. “These approaches fail to build skills or address motivation,” he said. FIU suggests parents work with teachers to make sure a child’s plan includes strategies that are actually making a difference, such as:
- Praising good behavior right away and setting clear, consistent expectations.
- A daily report card, where the teacher sets a few goals, tracks them each day and sends the results home so the child can earn rewards for meeting them.
- Turning “more time” into a specific goal with regular check-ins, instead of simply extending the deadline.
Whether a child should take medication is a decision for families and their doctor. The study did not test long-term effects or side effects.
What the study found
Compared with a placebo, a dummy pill, stimulant medication raised the amount of seatwork children finished per minute by 22% and raised quiz scores by 3.9 points, according to the journal article. The journal reports that medication cut classroom rule-breaking by 37% and behavior therapy by 61%. No accommodation, alone or combined with other treatments, significantly improved behavior or grades.
How the study worked
The trial enrolled 280 children in kindergarten through sixth grade, mostly boys, with an average age of almost 9; 255 started and 235 finished. It ran at FIU’s Summer Treatment Program, a summer program that includes classroom time, from 2022 to 2025. In this crossover design, each child spent time under different combinations of accommodations, behavior therapy and either medication or placebo, so researchers could compare children with themselves.
The authors caution that a well-run summer program is not an ordinary school, and they expect the benefits of any treatment to be weaker in real classrooms. They also say some children may still benefit from particular accommodations, which a companion study is examining. The work builds on research by the late William E. Pelham Jr., who founded FIU’s Center for Children and Families.
Source: Florida International University, “Common ADHD classroom accommodations may not help students succeed, FIU study finds,” Nov. 13, 2026; JAMA Pediatrics, “Attention-Deficit/Hyperactivity Disorder Accommodations, Behavior Therapy, and Stimulant Medication: A Randomized Clinical Trial”; JAMA Network media summary, Nov. 13, 2026.